RGX-202

FDA endorses speedy approval path for Regenxbio Duchenne gene therapy
BioPharma Dive
Mon, 11/18/24 - 06:32 pm
Rengexbio
DMD
gene therapy
FDA
RGX-202
Regenxbio data suggest ‘niche’ in Duchenne gene therapy
BioPharma Dive
Thu, 03/7/24 - 11:05 am
Regenxbio
Duchenne Muscular Dystrophy
DMD
RGX-202
Sarepta Therapeutics
Elevidys
Duchenne muscular dystrophy’s progress so far in 2023
Clinical Trials Arena
Wed, 02/22/23 - 10:00 am
Duchenne Muscular Dystrophy
DMD
Santhera Pharmaceuticals
ReveraGen
vamorolone
Regenxbio
RGX-202
Rgenix Banks $40 Million in Series C Round
CP WIre
Tue, 10/9/18 - 09:53 am
Rgenix
RGX-104
RGX-202
oncology
Rgenix Banks $40 Million in Series C Round
Tue, 10/9/18 - 09:25 am
Rgenix
RGX-104
RGX-202